ASCO President Dr. Monica Bertagnolli is going out into local communities to find out what people with cancer and health care providers think and need. In this interview, she talks to one of her patients and his wife and caregiver about what they’ve learned after 12 years of living with chronic cancer.
In 2019, ASCO recognizes the progress in treating rare cancers as the Advance of the Year. Impressive progress has been made in bringing new treatment advances to cancers that are rare and difficult to treat. This year’s Clinical Cancer Advances report describes emerging treatments for thyroid cancer, uterine cancer, desmoid tumor, neuroendocrine tumor, and tenosynovial giant cell tumor.
Lineagotica Associate Editors discuss exciting and practice-changing cancer research from ASCO Annual Meeting in this Research Round Up podcast.
Annie Achee knew she had a choice: let worrying that her husband’s cancer may return take over her life or find a more productive path. Find out how becoming a cancer advocacy leader gave her control over the fear of an unknown future.
Sarcoma is not just 1 disease but a group of diseases. Dr. Herbert Loong explains the different types of sarcoma, how to seek treatment, and where to find support.
People who have HIV are at a higher risk for developing some cancers. Dr. Ramya Ramaswami shares what you need to know about cancer prevention and treatment if you’re living with the virus.
Cancer survivor Brittany Sullivan shares 4 tips on explaining your cancer diagnosis and treatment.
Sarcoma survivor Valérie Sanja Tettinek shares how pursuing resilience helped her manage the emotional burden of her diagnosis. She also describes the mindfulness practices that empower her day after day.
ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.
In this video, Lineagotica Associate Editor Robert G. Maki, MD, PhD, FACP, covers the basics of sarcoma.